(4-(4,6-Difluorobenzo[d]thiazol-2-yl)piperazin-1-yl)(5,6-dihydro-1,4-dioxin-2-yl)methanone structure
|
Common Name | (4-(4,6-Difluorobenzo[d]thiazol-2-yl)piperazin-1-yl)(5,6-dihydro-1,4-dioxin-2-yl)methanone | ||
|---|---|---|---|---|
| CAS Number | 897482-60-9 | Molecular Weight | 367.4 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H15F2N3O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | (4-(4,6-Difluorobenzo[d]thiazol-2-yl)piperazin-1-yl)(5,6-dihydro-1,4-dioxin-2-yl)methanone |
|---|
| Molecular Formula | C16H15F2N3O3S |
|---|---|
| Molecular Weight | 367.4 |
| InChIKey | IIJWUQLOVFEIOW-UHFFFAOYSA-N |
| SMILES | C1CN(CCN1C2=NC3=C(C=C(C=C3S2)F)F)C(=O)C4=COCCO4 |
|
Name: High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
Source: ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id: HMS1303
|